Elisavet Lazaridou

Thessaloniki, ESYE12, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Association of Serum Levels of Total-IgE and Specific antiBP180 IgE Autoantibodies With Disease Activity and Severity in Patients With Bullous Pemphigoid.

Association of Serum Levels of Total-IgE and Specific antiBP180 IgE Autoantibodies With Disease Activity and Severity in Patients With Bullous Pemphigoid.

Journal: International journal of dermatology

Published: April 27, 2025

Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-AD.

Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-AD.

Journal: Dermatology and therapy

Published: February 13, 2025

Genetic variation of the gene COL17A1 and bullous pemphigoid in patients with neurodegenerative disorders.

Genetic variation of the gene COL17A1 and bullous pemphigoid in patients with neurodegenerative disorders.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 23, 2024

Correction: Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study.

Correction: Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study.

Journal: Dermatology and therapy

Published: September 28, 2024

Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study.

Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study.

Journal: Dermatology and therapy

Published: April 30, 2024

Real-world data on the effectiveness of brodalumab in patients with moderate-to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study).

Real-world data on the effectiveness of brodalumab in patients with moderate-to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study).

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: June 27, 2023

Pharmacogenetic Analysis of the MIR146A rs2910164 and MIR155 rs767649 Polymorphisms and Response to Anti-TNF Treatment in Patients with Crohn's Disease and Psoriasis.

Pharmacogenetic Analysis of the MIR146A rs2910164 and MIR155 rs767649 Polymorphisms and Response to Anti-TNF Treatment in Patients with Crohn's Disease and Psoriasis.

Journal: Genes

Published: December 03, 2022

Real-world clinical outcomes of treatment with brodalumab in patients with moderate-to-severe psoriasis: a retrospective, 24-month experience from four academic dermatology centers in Greece.

Real-world clinical outcomes of treatment with brodalumab in patients with moderate-to-severe psoriasis: a retrospective, 24-month experience from four academic dermatology centers in Greece.

Journal: The Journal of dermatological treatment

Published: August 24, 2022

Patch Testing in Patients With Alopecia Areata: A Case-series Study.

Patch Testing in Patients With Alopecia Areata: A Case-series Study.

Journal: Dermatology practical & conceptual

Published: January 29, 2022

Real world experience of brodalumab treatment in patients with moderate-to-severe plaque psoriasis in the Greek population: Results from an interim analysis of the BrIDGE study.

Real world experience of brodalumab treatment in patients with moderate-to-severe plaque psoriasis in the Greek population: Results from an interim analysis of the BrIDGE study.

Journal: Dermatologic therapy

Published: January 13, 2022

Sub-population analysis of patients with plaque psoriasis treated with calcipotriol/betamethasone aerosol foam; effectiveness and patient satisfaction, according to baseline disease severity and prior psoriasis treatment experience, in a Greek population.

Sub-population analysis of patients with plaque psoriasis treated with calcipotriol/betamethasone aerosol foam; effectiveness and patient satisfaction, according to baseline disease severity and prior psoriasis treatment experience, in a Greek population.

Journal: Dermatologic therapy

Published: January 12, 2022

Topical immunotherapy treatment of alopecia areata with diphenylcyclopropenone: Regulatory T cells as biomarkers for treatment response.

Topical immunotherapy treatment of alopecia areata with diphenylcyclopropenone: Regulatory T cells as biomarkers for treatment response.

Journal: Dermatologic therapy

Published: October 31, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026